DiaSys offers a new enzymatic HbA1c assay - HbA1c net FS - for diagnosis and long-term monitoring of diabetes. This innovative test is setting new standards for accuracy through its outstanding specificity and excellent precision. HbA1c net FS delivers results equivalent to HPLC. Interferences by hemoglobin variants or other blood components are minimized. The HbA1c net FS assay is standardized against the IFCC reference method and traceable to DCCT/NGSP. Fully automated handling on clinical chemistry platforms including onboard hemolysis allows convenient management of daily workloads.